Please assess the completion status of the following clinical trial:

Trial Title: Impact of Co Enzyme Q10 as Adjuvant Therapy to Letrozole on Spermiogram

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult male patients.~2. Aged 18 - 60 years.~3. Confirmed diagnosis with idiopathic Oligo-Astheno-Teratozoospermia (iOAT) syndrome.~Exclusion Criteria:~1. Patients who have been found to have additional infertility causes, such as varicocele or Obstruction of the ejaculatory duct.~2. Those who have had surgery for male factor infertility.~3. Patients with infections such as STD.~4. Patient with renal or liver disease~5. Incomplete patient data

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Group A (Type: SHAM_COMPARATOR): group A (29) patients received letrozole 2.5mg twice weekly for 3 months
- Group B (Type: EXPERIMENTAL): Group B (38) patients receive letrozole 2.5mg twice a week plus Co Q10 400 mg per day for 3 months

Based on this trial design, predict the completion outcome and termination type (if applicable).